NIH-funded research R01 grant

Using focused ultrasound and nanoemulsions to enhance drug delivery to the brain

Official title: Next generation transcranial ultrasound-based neuromodulation using phase shift nanoemulsions

Funded at Vanderbilt University Medical Center · NIH-11218703 · Data updated 2026-11-12

This study is exploring a new way to help deliver medicine directly to the brain using sound waves and tiny liquid particles, which could make treatments for brain conditions work better.

More Ultrasound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionVanderbilt University Medical Center
NIH-funded
Lab location1 site (Nashville, United States)
Project startFebruary 1, 2023
Project endApril 23, 2025
Funding year2025
Award (this year)$78,621
NIH project number3R01MH132022-03S1
Project IDNIH-11218703 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research would include individuals with neurological conditions that require targeted drug delivery to the brain.

Less likely to help

Patients with conditions that do not involve the brain or do not require drug delivery through the blood-brain barrier may not benefit from this research.

What this research studies

This research aims to develop a new method for delivering drugs to the brain using focused ultrasound (FUS) combined with phase shift nanoemulsions (PSNEs). The approach involves creating tiny liquid particles that can carry medication and become microbubbles when exposed to ultrasound, allowing for targeted drug release in specific areas of the brain. By enhancing the permeability of the blood-brain barrier, this technique could improve the effectiveness of treatments for various neurological conditions. The research will first be tested in non-human primates before moving to human applications.

Why it matters

Potential benefit: If successful, this research could lead to more effective treatments for neurological disorders by improving drug delivery to the brain.

How similar studies have gone: While focused ultrasound has been explored in other contexts, the combination with phase shift nanoemulsions represents a novel approach that has not been extensively tested.

Where this research is happening

  • Vanderbilt University Medical Center
    Nashville, United States
    Active

Researchers

  • Principal investigator: Caskey, Charles F — Vanderbilt University Medical Center
  • Study coordinator: Caskey, Charles F

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.